Treatment with kaempferol suppresses breast cancer cell growth caused by estrogen and triclosan in cellular and xenograft breast cancer models

Journal of Nutritional Biochemistry

Volumn 28, Issue , 2016, Pages 70-82

  Kim, Seung Hee ^a   Hwang, Kyung A ^a   Choi, Kyung Chul ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Apoptosis; Breast cancer; Estrogen receptor; Kaempferol; Metastasis; Triclosan

Indexed keywords

CATHEPSIN D; CYCLIN D1; CYCLIN E; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; INSULIN RECEPTOR SUBSTRATE 1; KAEMPFEROL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PROTEIN BAX; PROTEIN KINASE B; PROTEIN P21; SOMATOMEDIN C RECEPTOR; TRICLOSAN; KAEMPFEROL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CANCER MODEL; CELL CYCLE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MCF 7 CELL LINE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR VOLUME; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING; ANIMAL; BIOLOGICAL MODEL; BREAST TUMOR; CELL PROLIFERATION; DRUG EFFECTS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL PROLIFERATION; ESTROGENS; FEMALE; HETEROGRAFTS; HUMANS; KAEMPFEROLS; MICE; MODELS, BIOLOGICAL; PHOSPHORYLATION; TRICLOSAN;

EID: 84957798907     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.09.027     Document Type: Article

References (61)

1. Danial N.N., Korsmeyer S.J. Cell death: critical control points. Cell 2004, 116:205-219.
2. Kastan M.B., Bartek J. Cell-cycle checkpoints and cancer. Nature 2004, 432:316-323.
3. Prehn R.T. Tumor progression and homeostasis. Adv Cancer Res 1976, 23:203-236.
4. Branca F., Lorenzetti S. Health effects of phytoestrogens. Forum Nutr 2005, 100-111.
5. Kim S.H., Choi K.C. Anti-cancer effect and underlying mechanism(s) of kaempferol, a phytoestrogen, on the regulation of apoptosis in diverse cancer cell models. Toxicol Res 2013, 29:229-234.
6. Dixon R.A. Phytoestrogens. Annu Rev Plant Biol 2004, 55:225-261.
7. Park M.A., Hwang K.A., Choi K.C. Diverse animal models to examine potential role(s) and mechanism of endocrine disrupting chemicals on the tumor progression and prevention: do they have tumorigenic or anti-tumorigenic property?. Lab Anim Res 2011, 27:265-273.
8. Beral V., Million Women Study C Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003, 362:419-427.
9. Yager J.D., Davidson N.E. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006, 354:270-282.
10. Ren W., Qiao Z., Wang H., Zhu L., Zhang L. Flavonoids: promising anticancer agents. Med Res Rev 2003, 23:519-534.
11. Le Bail J.C., Varnat F., Nicolas J.C., Habrioux G. Estrogenic and antiproliferative activities on MCF-human breast cancer cells by flavonoids. Cancer Lett 1998, 130:209-216.
12. Hui C., Qi X., Qianyong Z., Xiaoli P., Jundong Z., Mantian M. Flavonoids, flavonoid subclasses and breast cancer risk: a meta-analysis of epidemiologic studies. PLoS One 2013, 8:e54318.
13. Adlercreutz H., Mousavi Y., Clark J., Hockerstedt K., Hamalainen E., Wahala K., et al. Dietary phytoestrogens and cancer: in vitro and in vivo studies. J Steroid Biochem Mol Biol 1992, 41:331-337.
14. Park J.S., Rho H.S., Kim D.H., Chang I.S. Enzymatic preparation of kaempferol from green tea seed and its antioxidant activity. J Agric Food Chem 2006, 54:2951-2956.
15. Yoshikawa T., Naito Y., Kondo M. Ginkgo biloba leaf extract: review of biological actions and clinical applications. Antioxid Redox Signal 1999, 1:469-480.
16. Yoshida T., Konishi M., Horinaka M., Yasuda T., Goda A.E., Taniguchi H., et al. Kaempferol sensitizes colon cancer cells to TRAIL-induced apoptosis. Biochem Biophys Res Commun 2008, 375:129-133.
17. Kim B.W., Lee E.R., Min H.M., Jeong H.S., Ahn J.Y., Kim J.H., et al. Sustained ERK activation is involved in the kaempferol-induced apoptosis of breast cancer cells and is more evident under 3-culture condition. Cancer Biol Ther 2008, 7:1080-1089.
18. Kang J.W., Kim J.H., Song K., Kim S.H., Yoon J.H., Kim K.S. Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells. Phytother Res 2010, 24(Suppl. 1):S77-S82.
19. Huang W.W., Chiu Y.J., Fan M.J., Lu H.F., Yeh H.F., Li K.H., et al. Kaempferol induced apoptosis via endoplasmic reticulum stress and mitochondria-dependent pathway in human osteosarcoma U-OS cells. Mol Nutr Food Res 2010, 54:1585-1595.
20. Nguyen T.T., Tran E., Ong C.K., Lee S.K., Do P.T., Huynh T.T., et al. Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK. J Cell Physiol 2003, 197:110-121.
21. Chen A.Y., Chen Y.C. A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem 2013, 138:2099-2107.
22. Lee W.S., Lee E.G., Sung M.S., Yoo W.H. Kaempferol inhibits IL-1beta-stimulated, RANKL-mediated osteoclastogenesis via downregulation of MAPKs, c-Fos, and NFATc1. Inflammation 2014, 37:1221-1230.
23. Chen H.J., Lin C.M., Lee C.Y., Shih N.C., Peng S.F., Tsuzuki M., et al. Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-signaling pathways in U-OS human osteosarcoma cells. Oncol Rep 2013, 30:925-932.
24. Lee K.M., Lee D.E., Seo S.K., Hwang M.K., Heo Y.S., Lee K.W., et al. Phosphatidylinositol 3-kinase, a novel target molecule for the inhibitory effects of kaempferol on neoplastic cell transformation. Carcinogenesis 2010, 31:1338-1343.
25. Bedoux G., Roig B., Thomas O., Dupont V., Le Bot B. Occurrence and toxicity of antimicrobial triclosan and by-products in the environment. Environ Sci Pollut Res Int 2012, 19:1044-1065.
26. Darbre P.D. Environmental oestrogens, cosmetics and breast cancer. Best Pract Res Clin Endocrinol Metab 2006, 20:121-143.
27. Allmyr M., Harden F., Toms L.M., Mueller J.F., McLachlan M.S., Adolfsson-Erici M., et al. The influence of age and gender on triclosan concentrations in Australian human blood serum. Sci Total Environ 2008, 393:162-167.
28. Savage J.H., Matsui E.C., Wood R.A., Keet C.A. Urinary levels of triclosan and parabens are associated with aeroallergen and food sensitization. J Allergy Clin Immunol 2012, 130:453-460. [e7].
29. Calafat A.M., Ye X., Wong L.Y., Reidy J.A., Needham L.L. Urinary concentrations of triclosan in the U.S. population: 2003-2004. Environ Health Perspect 2008, 116:303-307.
30. Gee R.H., Charles A., Taylor N., Darbre P.D. Oestrogenic and androgenic activity of triclosan in breast cancer cells. J Appl Toxicol 2008, 28:78-91.
31. Kim S.H., Hwang K.A., Shim S.M., Choi K.C. Growth and migration of LNCaP prostate cancer cells are promoted by triclosan and benzophenone-via an androgen receptor signaling pathway. Environ Toxicol Pharmacol 2015, 39:568-576.
32. Kim J.Y., Yi B.R., Go R.E., Hwang K.A., Nam K.H., Choi K.C. Methoxychlor and triclosan stimulates ovarian cancer growth by regulating cell cycle- and apoptosis-related genes via an estrogen receptor-dependent pathway. Environ Toxicol Pharmacol 2014, 37:1264-1274.
33. Lee H.R., Hwang K.A., Nam K.H., Kim H.C., Choi K.C. Progression of breast cancer cells was enhanced by endocrine-disrupting chemicals, triclosan and octylphenol, via an estrogen receptor-dependent signaling pathway in cellular and mouse xenograft models. Chem Res Toxicol 2014, 27:834-842.
34. Rodricks J.V., Swenberg J.A., Borzelleca J.F., Maronpot R.R., Shipp A.M. Triclosan: a critical review of the experimental data and development of margins of safety for consumer products. Crit Rev Toxicol 2010, 40:422-484.
35. Dinwiddie M.T., Terry P.D., Chen J. Recent evidence regarding triclosan and cancer risk. Int J Environ Res Public Health 2014, 11:2209-2217.
36. Rochefort H., Garcia M., Glondu M., Laurent V., Liaudet E., Rey J.M., et al. Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview. Clin Chim Acta 2000, 291:157-170.
37. Lee H.R., Choi K.C. Potential role(s) of cysteine cathepsins in cancer progression and metastasis. J Biomed Res 2013, 14:1-7.
38. Albini A., Rosano C., Angelini G., Amaro A., Esposito A.I., Maramotti S., et al. Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors. Curr Med Chem 2014, 21:1129-1145.
39. Hwang K.A., Park M.A., Kang N.H., Yi B.R., Hyun S.H., Jeung E.B., et al. Anticancer effect of genistein on BG-ovarian cancer growth induced by 17 beta-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor alpha and insulin-like growth factor-receptor signaling pathways. Toxicol Appl Pharmacol 2013, 272:637-646.
40. Adlercreutz H. Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol 2002, 83:113-118.
41. Duffy C., Perez K., Partridge A. Implications of phytoestrogen intake for breast cancer. CA Cancer J Clin 2007, 57:260-277.
42. Lee H.R., Kim T.H., Choi K.C. Treatment with bisphenol A leads to the promotion of human breast cancer cells and alteration of cell cycle-related gene expressions, cyclin E and p27. J Biomed Res 2011, 12:215-223.
43. Knower K.C., To S.Q., Leung Y.K., Ho S.M., Clyne C.D. Endocrine disruption of the epigenome: a breast cancer link. Endocr Relat Cancer 2014, 21:T33-T55.
44. Fowler P.A., Bellingham M., Sinclair K.D., Evans N.P., Pocar P., Fischer B., et al. Impact of endocrine-disrupting compounds (EDCs) on female reproductive health. Mol Cell Endocrinol 2012, 355:231-239.
45. Jeung E.B., Choi K.C. Toxicological mechanism of endocrine disrupting chemicals: is estrogen receptor involved?. Toxicol Res 2010, 26:237-243.
46. Hwang K.A., Park S.H., Yi B.R., Choi K.C. Gene alterations of ovarian cancer cells expressing estrogen receptors by estrogen and bisphenol a using microarray analysis. Lab Anim Res 2011, 27:99-107.
47. Park M.A., Hwang K.A., Lee H.R., Yi B.R., Choi K.C. Cell growth of BG-ovarian cancer cells was promoted by 4-Tert-octylphenol and 4-Nonylphenol via downregulation of TGF-beta Receptor 2 and upregulation of c-myc. Toxicol Res 2011, 27:253-259.
48. Magee P.J., Rowland I.R. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 2004, 91:513-531.
49. Oh S.M., Kim Y.P., Chung K.H. Biphasic effects of kaempferol on the estrogenicity in human breast cancer cells. Arch Pharm Res 2006, 29:354-362.
50. Sachdev D., Yee D. The IGF system and breast cancer. Endocr Relat Cancer 2001, 8:197-209.
51. Chen W.F., Wong M.S. Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells. J Clin Endocrinol Metab 2004, 89:2351-2359.
52. Fagan D.H., Yee D. Crosstalk between IGF1R and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia 2008, 13:423-429.
53. Chang F., Lee J.T., Navolanic P.M., Steelman L.S., Shelton J.G., Blalock W.L., et al. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 2003, 17:590-603.
54. Reinmuth N., Fan F., Liu W., Parikh A.A., Stoeltzing O., Jung Y.D., et al. Impact of insulin-like growth factor receptor-function on angiogenesis, growth, and metastasis of colon cancer. Lab Invest 2002, 82:1377-1389.
55. Bestwick C.S., Milne L., Duthie S.J. Kaempferol induced inhibition of HL-60 cell growth results from a heterogeneous response, dominated by cell cycle alterations. Chem Biol Interact 2007, 170:76-85.
56. Kang G.Y., Lee E.R., Kim J.H., Jung J.W., Lim J., Kim S.K., et al. Downregulation of PLK-expression in kaempferol-induced apoptosis of MCF-cells. Eur J Pharmacol 2009, 611:17-21.
57. Siegelin M.D., Reuss D.E., Habel A., Herold-Mende C., von Deimling A. The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of surviving. Mol Cancer Ther 2008, 7:3566-3574.
58. Alenzi F.Q., Lotfy M., Wyse R. Swords of cell death: caspase activation and regulation. Asian Pac J Cancer Prev 2010, 11:271-280.
59. Phromnoi K., Yodkeeree S., Anuchapreeda S., Limtrakul P. Inhibition of MMP-activity and invasion of the MDA-MB-231 human invasive breast carcinoma cell line by bioflavonoids. Acta Pharmacol Sin 2009, 30:1169-1176.
60. Labbe D., Provencal M., Lamy S., Boivin D., Gingras D., Beliveau R. The flavonols quercetin, kaempferol, and myricetin inhibit hepatocyte growth factor-induced medulloblastoma cell migration. J Nutr 2009, 139:646-652.
61. Luo H., Rankin G.O., Juliano N., Jiang B.H., Chen Y.C. Kaempferol inhibits VEGF expression and in vitro angiogenesis through a novel ERK-NFkappaB-cMyc-p21 pathway. Food Chem 2012, 130:321-328.